Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical Trial

Empagliflozin use before on-pump CABG in patients with T2DM was associated with a reduced incidence of postoperative AKI without an increase in safety events. These findings warrant confirmation in larger clinical trials.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2025-04-15
DOI
https://doi.org/10.2337/dc24-2807
Citations
7
Primary Topic
Hyperglycemia and glycemic control in critically ill and hospitalized patients
Type
article
Field-Weighted Citation Impact
9.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical Trial

Fabiana Hanna Rached, Luís Alberto Oliveira Dallan, Desidério Favarato, Henrique Trombini Pinesi et al.
7 citations
Diabetes Care
Hyperglycemia and glycemic control in critically ill and hospitalized patients
9.06
article

Empagliflozin in Patients With Type 2 Diabetes Undergoing On-Pump CABG: The POST-CABGDM Randomized Clinical Trial

Fabiana Hanna Rached, Luís Alberto Oliveira Dallan, Desidério Favarato, Henrique Trombini Pinesi, Caio de Assis Moura Tavares, Simão Augusto Lottenberg, Fábio Grunspun Pitta, Eduardo Bello Martins, Larissa Justino, Eduardo Martelli Moreira, James A. de Lemos, Carlos Serrano, Eduardo Gomes Lima, Camila Talita Machado Barbosa, Paula Mathias Paulino Bolta, Roberto Kalil Filho, Letícia Neves Solon Carvalho, Bruno Mahler Mioto, Luís Roberto Palma Dallan, Marcelo Henrique Moreira Barbosa
article en
7 citations

Abstract

Empagliflozin use before on-pump CABG in patients with T2DM was associated with a reduced incidence of postoperative AKI without an increase in safety events. These findings warrant confirmation in larger clinical trials.

Diabetes CareVol. 48(6)
Hospital Israelita Albert Einstein (BR), Universidade Nove de Julho (BR), Hospital de Clínicas de Porto Alegre (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Openalex Percentile: Top 2%
Hyperglycemia and glycemic control in critically ill and hospitalized patients
9.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.